Validose

Brooklyn, NY · Founded 2017 · Privately Held (backing)

Developer of an intranasal drug delivery platform designed to deliver medication adherence solutions for clinical trials in real-time. Validose is based in Brooklyn, NY and was founded in 2017. It was valued at $6 million at its seed round in Jan 2025, the last priced event on record. It has raised $2 million across 1 recorded round; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$6.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$2.0M
Last round
Seed Round
Dec 2024
What is Validose worth?
$6.0MPrivateMarketView mark · Oct 2026

Valued at $6.0M at its seed round, Jan 2025. Nothing has traded since.

Free account
More of Validose with a free account
  • ·Watch Validose: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Validose funding history

1 rounds
DateRoundRaisedPost-money
Dec 2024Seed Round$1.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Validose valuation

Validose was valued at $6 million at its seed round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Validose raised?

Validose has raised $2 million across 1 recorded round since 2024. The largest was a $1.6 million seed round in Dec 2024.

Validose has filed 1 Form D with the SEC, most recently in Jan 2025 ($1.6 million sold to 2 investors).

How Validose's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Validose, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Validose

What is Validose worth?
Validose is valued at $6.0M as of Oct 2026. Valued at $6.0M at its seed round, Jan 2025. Nothing has traded since.
How much has Validose raised?
Validose has raised $2.0M in total funding across 1 recorded rounds.
When did Validose last raise?
Validose last raised in Dec 2024 (Seed Round), raising $1.6M.